Theratechnologies Inc T.TH

New Press Release - Theratechnologies Receives January 2024 PDUFA Goal Date for Tesamorelin F8 Formulation sBLA

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14, 2021. MONTREAL, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or...read article.

[Lee430]

Question, will the FDA aproval of F8 formula also include the Pen delivery system or is that a seperate aproval process?

[scarlet1967]

The pen injector is classified as a medical device which has to be approved separately. There are various classes of medical devices depending on the nature of the device, I believe the pen injector would be classed in the second category as it is used to penetrate the body! Some other medical devices are categorized at higher classes due to more complex uses. The higher classes the more complex

[Trogarzon]

No reason for this comapny to be public anymore.  It's a burden on shareholders since it defeats the whole pupose of valuating adequatly the fundamentals of the company regardless of the pipeline.

[Trogarzon]

They can say all they want the market is not appreciating the value of their pipeline and business but it's their job whatever the market environment to make shure it is and it ain't working.  Not at 40 cents it ain't.. why are they still running the show overthere.  I don'y know many companies that keep their head when they destroy as much company valuation. Whe are not

[Trogarzon]

They put out a milestone today.. hey F8 is submitted.. good news now.  What happens well it goes down again.. hey 30 cents why not.  Why because the market like always.. shure but also.. becuase what is good about having submitted F8.. well nothing on that. Is it gonna make it better, are they gonna sell more, are they benifit from doing just that... submitting F8.  Well hell no

[Trogarzon]

The reverse split was such a mistep in the way it was orchestrated that the end result is a total valuation disconect.  The company is now a price, a 1.75$ price that in reality is 40 cents. It's not 0.7 sales  multiple below the sector already low 1.5 average.  Ok they need the Nasdaq.. for what.. why do you need the Nasdaq.  To cut the stockprice in 3 post reverse split.&